BioHealth News Archive
Novel Nanotechnology Supercharges Immune System Molecules to Fight Cancer
Novel Nanotechnology Supercharges Immune System Molecules to Fight Cancer Researchers from Cytimmune Sciences presented new data at a cancer therapeutics conference in Boston, MA…
Read More
Deloitte remains largest healthcare consulting firm in United States
Deloitte Consulting remained atop Modern Healthcare’s annual ranking of the largest healthcare management consulting firms based in the US. Deloitte US’ sizable healthcare consulting…
Read More
Intralytix receives Phase II Fast Track NIH SBIR contract
Intralytix receives Phase II Fast Track NIH SBIR contract to continue development of a universal, scale-independent AI-based platform for manufacturing high titer bacteriophage preparations…
Read More
Tonix Pharmaceuticals develops monkeypox vaccine for future by looking at past
Tonix Pharmaceuticals, a company that has a research lab in Frederick, is developing a vaccine to prepare for a future where the monkeypox virus…
Read More
Biotech And Drug Development (Audio) – Bloomberg
Dr. Amrie Grammer, co-founder of AMPEL BioSolutions, joins the show to discuss biotech and her company Hosted by Paul Sweeney and Matt Miller. …
Read More
Emergent BioSolutions to acquire PaxVax and two travel vaccines in $270M deal | Fierce Pharma
After getting smallpox vaccine ACAM2000 from Sanofi and an anthrax treatment called raxibacumab from GlaxoSmithKline, Emergent BioSolutions is buying again, this time an entire…
Read More
Don’t get distracted over ARPA-H fight; let’s win the bigger prize | Maryland Daily Record
Congress has approved a new agency — the Advanced Research Projects Agency for Health (ARPA-H) — that will ‘supercharge’ breakthrough medical research and provide…
Read More
Eyeing $1B in annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735M | Fierce Pharma
Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine expert PaxVax, the frequent…
Read More
8 new high priority funding opportunities
We just released 8 new high priority funding opportunities where your company can make a difference in meeting the needs of cancer patients… Please…
Read More
Maryland’s RoosterBio and Seattle’s AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with RoosterBio…
Read MoreD.C. Area Life Sciences Market Down to 1.4% Vacancy – Commercial Observer
The Washington, D.C./Baltimore region continued to see a tightening in its life sciences real estate market. In particular, the region saw a decrease in…
Read More
Bio Tax Credit | Maryland Department of Commerce
The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin accepting applications as follows: Commerce will begin accepting Form…
Read More
Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older
Aug 15, 2022 If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax COVID-19 Vaccine, Adjuvanted could…
Read More
Technical.ly: 2 new medtech startups will spin out of Johns Hopkins research fund grants
Two new medical startups, focusing on addressing vision loss and catheter-associated urinary tract infections (UTIs), are on the horizon thanks to the $200,000 in…
Read More
Chancellor’s Message: VISION 2030 — From Excellence to Preeminence
VISION 2030: From Excellence to Preeminence This summer, the University System of Maryland unveiled a new 10-year strategic plan—Vision 2030: From Excellence to Preeminence.…
Read More